Have you ever wondered why two brands of pharmaceuticals with similar efficacy and safety measures are prescribed differently? Often this is more influenced by emotion than rational thinking.
Find out more https://goo.gl/e3yMcl
The only way is mobile: Drug forecasting in the age of personalized medicineSKIM
Presented by:
Robert Dossin, Client Solutions Director Europe
With the odds stacked against a new product in a complex, competitive market, one pharma client needed insights that traditional market research methods just couldn’t touch. Which patients? What type? How many?
What the brand team didn’t expect was an approach that captured prescribing intent with such precision that it turned round conventional thinking and elevated a ‘simple forecast’ to a robust, compelling evidence base for a winning strategic direction. Powering fresh momentum, confident decisions, more impactful customer engagement and better informed physicians, the ‘in-the-moment’ clarity of mobile forecasting proved the albeit unanticipated driving force that ensured a successful launch.
SKIM is an international customer insights agency. We guide our clients with their product communication and portfolio management decisions in the healthcare industry. We are uniquely placed to debate the issues around decision dilemmas because we understand the way customers make choices.
PMRC USA 2017 - Mobile Forecasting in the Age of Personalized MedicineSKIM
How can the pharma industry harness in-the-moment mobile forecasting to get closer to the point of prescription? To answer this question, we presented a case study at the Pharma Market Research Conference (PMRC) USA 2017, which was held on Feb 1-2, 2017 in Parsippany, New Jersey.
Drug Forecasting in the Age of Personalized Medicine – The Only Way is Mobile!SKIM
An innovative approach to drug forecasting – in-the-moment mobile research enables collection of robust data close to the point of prescription. Applied to forecasting the advantages are significant – individualized data accounts for the increasingly personalized approaches to treatment based on bio-markers. Furthermore, the mobile platform enables collection of more qualitative information to supplement the quantitative, delivering robust yet holistic outcomes.
85% of clinical trials fail to recruit enough patients, 80% fail to finish on time. A key issue is 70% of patients live more that 2 hours from the study site. Wearable devices can support the collection of real world data in the patients home as well as create novel endpoints
A 3+ Year Review of 12 StartUp Health Companies ProgressGary Monk
On 10/26/15 I met 12 StartUp Health companies at the Cleveland Clinic. This annotated presentation shows where these companies are today in terms of activity and funding status. Some encouraging reading (See slide 15 summary)
Is healthcare getting safer? Professor Charles Vincent - Patient safety lead, Oxford AHSN
Presentation from the Patient Safety Collaborative launch event held in London on 14 October 2014
More information at http://www.nhsiq.nhs.uk/improvement-programmes/patient-safety/patient-safety-collaboratives.aspx
The only way is mobile: Drug forecasting in the age of personalized medicineSKIM
Presented by:
Robert Dossin, Client Solutions Director Europe
With the odds stacked against a new product in a complex, competitive market, one pharma client needed insights that traditional market research methods just couldn’t touch. Which patients? What type? How many?
What the brand team didn’t expect was an approach that captured prescribing intent with such precision that it turned round conventional thinking and elevated a ‘simple forecast’ to a robust, compelling evidence base for a winning strategic direction. Powering fresh momentum, confident decisions, more impactful customer engagement and better informed physicians, the ‘in-the-moment’ clarity of mobile forecasting proved the albeit unanticipated driving force that ensured a successful launch.
SKIM is an international customer insights agency. We guide our clients with their product communication and portfolio management decisions in the healthcare industry. We are uniquely placed to debate the issues around decision dilemmas because we understand the way customers make choices.
PMRC USA 2017 - Mobile Forecasting in the Age of Personalized MedicineSKIM
How can the pharma industry harness in-the-moment mobile forecasting to get closer to the point of prescription? To answer this question, we presented a case study at the Pharma Market Research Conference (PMRC) USA 2017, which was held on Feb 1-2, 2017 in Parsippany, New Jersey.
Drug Forecasting in the Age of Personalized Medicine – The Only Way is Mobile!SKIM
An innovative approach to drug forecasting – in-the-moment mobile research enables collection of robust data close to the point of prescription. Applied to forecasting the advantages are significant – individualized data accounts for the increasingly personalized approaches to treatment based on bio-markers. Furthermore, the mobile platform enables collection of more qualitative information to supplement the quantitative, delivering robust yet holistic outcomes.
85% of clinical trials fail to recruit enough patients, 80% fail to finish on time. A key issue is 70% of patients live more that 2 hours from the study site. Wearable devices can support the collection of real world data in the patients home as well as create novel endpoints
A 3+ Year Review of 12 StartUp Health Companies ProgressGary Monk
On 10/26/15 I met 12 StartUp Health companies at the Cleveland Clinic. This annotated presentation shows where these companies are today in terms of activity and funding status. Some encouraging reading (See slide 15 summary)
Is healthcare getting safer? Professor Charles Vincent - Patient safety lead, Oxford AHSN
Presentation from the Patient Safety Collaborative launch event held in London on 14 October 2014
More information at http://www.nhsiq.nhs.uk/improvement-programmes/patient-safety/patient-safety-collaboratives.aspx
Medisafe_What's Next in RWE_mHealth IsraelLevi Shapiro
Presentation by Medisafe CEO, Omri Shor, Oct 19, 2021, for the mHealth Israel community.
- Medisafe’s Patient Engagement Platform
- Real World Evidence: Economic Impact for Pharma
- Connecting Pharma to patients
- Case Study: Supporting Patients through Digital Platform
-
More than 200 million medication errors occur in NHS per year, now there’s a way to improve dispensing accuracy, reduce administration errors and improve adherence at the same time.
In June, 2015 Thinque's futurist-in-residence, Anders Sorman-Nilsson was invited to open NaviHealth's inaugural conference in Nashville, Tennessee to address the Future of Healthcare, in the context of Post-Acute Care. In this slidedeck which summarises the key strategic points from his keynote, you will gain access to insights affecting the digital paradigm shift in how we think about and manage our health, both proactively and reactively. The Future of Healthcare certainly looks more like Startrek than like bloodletting. Here are the slides, courtesy of Keppler Speakers and Thinque.
What's Next in RWE_Amy Rudolph_Novartis_mHealth IsraelLevi Shapiro
Overview of the
- Healthcare ecosystem complexity increasing rapidly
- Pharma industry is facing a crisis: trends shaping the industry
- RWE complements RCTs and captures implementation of innovation
- RWE is one component of the integrated evidence needed for stakeholders
- Integrated Evidence: Optimizing patient access
- Integrated Evidence: Label expansion
- Maximizing the value of data requires a scalable platform and expertise
Paul Coplan, VP, Johnson & Johnson_mHealth IsraelLevi Shapiro
Pesentation, October 19th, 2021: What’s Next in RWE for Medical Devices: The Art of the Possible. Presented by Paul Coplan, ScD, MBA, FISPE, Vice President, Med Device Epidemiology and RWD Sciences, Johnson & Johnson; Adjunct Professor, Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Perelman School of Medicine; Fellow of the International Society of Pharmacoepidemiology
- Why RWE is Important for Medical Devices: Challenges with Clinical Trials of Medical Devices (Blinding, Surgeon skill/technique, Hospital process, Product modifications, Long term Follow up, Enrolment challenges)
- Types of Real-World Data Sources (Complaints like MAUDE, Eudramed and Company Databases, Hospital Databases, Electronic Health Records, Claims, Registries, Patient surveys, Surgeon surveys, PROs, Patient Preferences, wearables, sensors, social media, Surgical videos, device generated data, radiographic images)
- FDA CDRH Report on RWE Examples for Regulatory Decisions
- J&J Med Device Epidemiology & Real-World Data Sciences
- US National Evaluation System for Health Technology (NEST)
- RWE for Safety Assessments: Cobalt in Implants and at Work and Risk of Cancer
- Summary of Cobalt Exposure and All-Site Cancer Risk, by Study Type
- Comparative Effectiveness Studies Using RWE
- Summary
a. Use of RWE is important to benefit patients globally and enhance the safety and innovation of medical devices
b. Regulators are interested in using RWE for regulatory decisions but data quality and evidence needs to be regulatory grade
c. NEST has been a useful forum to advance the use of RWE for regulatory decisions in the US
d. RWE can be used for safety assessments, regulatory decisions, comparative effectiveness research, and R&D of products
The Health Payer Council, headed up by Roger Green and Associates, Inc. (RG+A) takes a look at the perceptions medical directors and pharmacy directors of different cost management and payer strategies. Take a look.
Artificial Intelligence—Infinite Possibilities: Adam Hanina, AICure (Digital ...Jill Gilbert
How are Pharma and health systems using artificial intelligence to improve outcomes and lower costs? AiCure will present a live demonstration of how their AI platform will tackle a major challenge taxing the healthcare system — medication adherence. You’ll see how their technology will not only positively impact clinical trial success rates and improve patient behavior, but will also help reduce the costs attributed to our nationwide lack of medication compliance.
Artificial Intelligence and Machine Learning will have a profound effect in transforming healthcare and bridging the historical gap of information asymmetry between the healthcare ecosystem and people
Patient Centricity: EHR Pillars to Patient CentricityDayOne
AT the DayOne Experts - Next Generation Clinical Trials, Randy Ramin-Wright from Clinerion demonstrated how patient recruitment works in the digital age.
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...Levi Shapiro
Presentation by Michael Seewald, Michael Seewald, Ph.D.
Global Head Evidence, AstraZeneca Biopharmaceuticals for mHealth Israel, October 19th, 2021.
Real-World Data is able to uncover local unmet medical need – Call to action to build Learning Healthcare Systems. Significant Variations in Care and Large Potential for Improvement. Real-World Data helps to benchmark efficient use of resources and detect “waste”. Healthcare systems need to address the problem of waste. But fundamental change is hard, and progress slow. Outcomes Transparency Improves ComplianceExample: Swedish myocardial infarction registry. Outcomes Transparency Improves Compliance. Example: Swedish myocardial infarction registry. Improving Outcomes and Creating Value will continue to guide Learning Healthcare Systems- enabled by RWD. Four technological trends as accelerators on our path. Empowered patients- Molecular screening and 24/7 monitoring driving a step change in diagnosis. Algorithmic decision-making: Artificial intelligence supports physician intelligence. Evidence-generating healthcare systemsLive insights on clinical efficacy from digital monitoring. 360° care delivery. Home replaces hospital via digital therapeutics and on-demand remote support. AstraZeneca Areas of Partnering Interest: (https://www.astrazeneca.com/partnering/our-areas-of-partnering-interest.html).
mHealth Israel_Growth Opportunities in Clinical Trial Execution_Craig LipsetLevi Shapiro
Craig Lipsent, former Worldwide Head of Clinical Innovation at Pfizer, presents to the mHealth Israel Community, Feb, 2020. Theme: Clinical trials are vital for developing new medicines but they are broken. Clinical trial trends include the increasing attention and investment in participant & investigator experience
Digitization and innovative data capture. Forecast for clinical trials will be decentralized, distributed, democratized and disruptive.
Customer journey: what keyless check in teaches usSKIM
Presented by:
Wessel Roose, Research Manager, and Patricia Dominguez, Senior Research Analyst
Alex Xiaoguang Zhu, Manager, and Sanjay Sugarek, Manager
By taking a journey view, the check-in experience can be evaluated above individual touch-points, revealing underlying expectations. Hence, marketers should go beyond traditional metrics to determine and understand customer experience within the context of customer journey.
In this month's webinar, we shared insights from our decision journey mapping studies showing the tremendous value when understanding customer experience from this perspective.
Find out more at http://skimgroup.com/webinar-customer-journey-mapping.
Big Data often has demographic and behavioral data, but little to no attitudinal information. This presentation describes the many challenges in using survey data to add attitudinal information.
Find out more https://goo.gl/qRg6IK
Medisafe_What's Next in RWE_mHealth IsraelLevi Shapiro
Presentation by Medisafe CEO, Omri Shor, Oct 19, 2021, for the mHealth Israel community.
- Medisafe’s Patient Engagement Platform
- Real World Evidence: Economic Impact for Pharma
- Connecting Pharma to patients
- Case Study: Supporting Patients through Digital Platform
-
More than 200 million medication errors occur in NHS per year, now there’s a way to improve dispensing accuracy, reduce administration errors and improve adherence at the same time.
In June, 2015 Thinque's futurist-in-residence, Anders Sorman-Nilsson was invited to open NaviHealth's inaugural conference in Nashville, Tennessee to address the Future of Healthcare, in the context of Post-Acute Care. In this slidedeck which summarises the key strategic points from his keynote, you will gain access to insights affecting the digital paradigm shift in how we think about and manage our health, both proactively and reactively. The Future of Healthcare certainly looks more like Startrek than like bloodletting. Here are the slides, courtesy of Keppler Speakers and Thinque.
What's Next in RWE_Amy Rudolph_Novartis_mHealth IsraelLevi Shapiro
Overview of the
- Healthcare ecosystem complexity increasing rapidly
- Pharma industry is facing a crisis: trends shaping the industry
- RWE complements RCTs and captures implementation of innovation
- RWE is one component of the integrated evidence needed for stakeholders
- Integrated Evidence: Optimizing patient access
- Integrated Evidence: Label expansion
- Maximizing the value of data requires a scalable platform and expertise
Paul Coplan, VP, Johnson & Johnson_mHealth IsraelLevi Shapiro
Pesentation, October 19th, 2021: What’s Next in RWE for Medical Devices: The Art of the Possible. Presented by Paul Coplan, ScD, MBA, FISPE, Vice President, Med Device Epidemiology and RWD Sciences, Johnson & Johnson; Adjunct Professor, Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Perelman School of Medicine; Fellow of the International Society of Pharmacoepidemiology
- Why RWE is Important for Medical Devices: Challenges with Clinical Trials of Medical Devices (Blinding, Surgeon skill/technique, Hospital process, Product modifications, Long term Follow up, Enrolment challenges)
- Types of Real-World Data Sources (Complaints like MAUDE, Eudramed and Company Databases, Hospital Databases, Electronic Health Records, Claims, Registries, Patient surveys, Surgeon surveys, PROs, Patient Preferences, wearables, sensors, social media, Surgical videos, device generated data, radiographic images)
- FDA CDRH Report on RWE Examples for Regulatory Decisions
- J&J Med Device Epidemiology & Real-World Data Sciences
- US National Evaluation System for Health Technology (NEST)
- RWE for Safety Assessments: Cobalt in Implants and at Work and Risk of Cancer
- Summary of Cobalt Exposure and All-Site Cancer Risk, by Study Type
- Comparative Effectiveness Studies Using RWE
- Summary
a. Use of RWE is important to benefit patients globally and enhance the safety and innovation of medical devices
b. Regulators are interested in using RWE for regulatory decisions but data quality and evidence needs to be regulatory grade
c. NEST has been a useful forum to advance the use of RWE for regulatory decisions in the US
d. RWE can be used for safety assessments, regulatory decisions, comparative effectiveness research, and R&D of products
The Health Payer Council, headed up by Roger Green and Associates, Inc. (RG+A) takes a look at the perceptions medical directors and pharmacy directors of different cost management and payer strategies. Take a look.
Artificial Intelligence—Infinite Possibilities: Adam Hanina, AICure (Digital ...Jill Gilbert
How are Pharma and health systems using artificial intelligence to improve outcomes and lower costs? AiCure will present a live demonstration of how their AI platform will tackle a major challenge taxing the healthcare system — medication adherence. You’ll see how their technology will not only positively impact clinical trial success rates and improve patient behavior, but will also help reduce the costs attributed to our nationwide lack of medication compliance.
Artificial Intelligence and Machine Learning will have a profound effect in transforming healthcare and bridging the historical gap of information asymmetry between the healthcare ecosystem and people
Patient Centricity: EHR Pillars to Patient CentricityDayOne
AT the DayOne Experts - Next Generation Clinical Trials, Randy Ramin-Wright from Clinerion demonstrated how patient recruitment works in the digital age.
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...Levi Shapiro
Presentation by Michael Seewald, Michael Seewald, Ph.D.
Global Head Evidence, AstraZeneca Biopharmaceuticals for mHealth Israel, October 19th, 2021.
Real-World Data is able to uncover local unmet medical need – Call to action to build Learning Healthcare Systems. Significant Variations in Care and Large Potential for Improvement. Real-World Data helps to benchmark efficient use of resources and detect “waste”. Healthcare systems need to address the problem of waste. But fundamental change is hard, and progress slow. Outcomes Transparency Improves ComplianceExample: Swedish myocardial infarction registry. Outcomes Transparency Improves Compliance. Example: Swedish myocardial infarction registry. Improving Outcomes and Creating Value will continue to guide Learning Healthcare Systems- enabled by RWD. Four technological trends as accelerators on our path. Empowered patients- Molecular screening and 24/7 monitoring driving a step change in diagnosis. Algorithmic decision-making: Artificial intelligence supports physician intelligence. Evidence-generating healthcare systemsLive insights on clinical efficacy from digital monitoring. 360° care delivery. Home replaces hospital via digital therapeutics and on-demand remote support. AstraZeneca Areas of Partnering Interest: (https://www.astrazeneca.com/partnering/our-areas-of-partnering-interest.html).
mHealth Israel_Growth Opportunities in Clinical Trial Execution_Craig LipsetLevi Shapiro
Craig Lipsent, former Worldwide Head of Clinical Innovation at Pfizer, presents to the mHealth Israel Community, Feb, 2020. Theme: Clinical trials are vital for developing new medicines but they are broken. Clinical trial trends include the increasing attention and investment in participant & investigator experience
Digitization and innovative data capture. Forecast for clinical trials will be decentralized, distributed, democratized and disruptive.
Customer journey: what keyless check in teaches usSKIM
Presented by:
Wessel Roose, Research Manager, and Patricia Dominguez, Senior Research Analyst
Alex Xiaoguang Zhu, Manager, and Sanjay Sugarek, Manager
By taking a journey view, the check-in experience can be evaluated above individual touch-points, revealing underlying expectations. Hence, marketers should go beyond traditional metrics to determine and understand customer experience within the context of customer journey.
In this month's webinar, we shared insights from our decision journey mapping studies showing the tremendous value when understanding customer experience from this perspective.
Find out more at http://skimgroup.com/webinar-customer-journey-mapping.
Big Data often has demographic and behavioral data, but little to no attitudinal information. This presentation describes the many challenges in using survey data to add attitudinal information.
Find out more https://goo.gl/qRg6IK
Together with Clorox, we presented our case about claimstorming in a 2-day Quirk’s Event in Orange County, California from February 28 to March 1.
During our session, we shared a case study of how Clorox’s Kingsford Charcoal brand team worked with us to develop a new set of claims to achieve specific marketing objectives for the brand.
Find out more https://goo.gl/v2AFVL
AT&T’s insight acceleration: from 6 weeks to 22 hour researchSKIM
Presented by:
Emily Toomey, Lead Manager, Social Media & Digital Advertising Insights at AT&T
Mike Mabey, VP Client Solutions Americas at SKIM
Three years ago, AT&T and SKIM began a partnership and journey towards shorter timelines for research. At that time, it was typically taking 6 weeks to conduct message tests, concept tests and print ad tests.
It started with a simple urgent request: AT&T needs to test new messages, and needs recommendations for message to use in 3 weeks in order to give the creative team enough time to create the ads. Could we do it?
At that time, every project was ad hoc custom work. So this seemingly simple but challenging request from AT&T started SKIM and AT&T on a 3-year and continuing journey to streamlining research and insights processes. And today, we have cut the 3-week timeline even more drastically and can deliver message test insights within 24 hours.
We discussed the steps, challenges, processes and changes clients should consider in order to deliver insights faster. We also showed the templates and processes we are using to achieve fast turnaround.
Bundling - a new approach using Menu Based ConjointSKIM
Presented by:
Wessel Roose, Research Manager based in Rotterdam
As a service provider, for example if your brand is a financial institution or telecom company, you may try to increase your revenue by cross-selling additional services to your current customers.
One way to achieve this is offering multiple services in a “bundle” and making the bundle attractive to customers by offering it at a discount.
At our Research & Results workshop, we shared how to define bundles and optimize revenue by bundling. This is a new approach using our Menu Based Conjoint (MBC), our innovative method specifically designed for markets where the purchase choice is based on a menu.
Find out more at http://skimgroup.com/menu-based-choice-modeling.
Unspoken: SKIM's mobile implicit research innovationSKIM
Mobile devices are everywhere, and changing everything. As a research industry we have to adjust to this new reality if we want to stay in touch with who our customers really are.
By combining intuitive mobile techniques with psychological theory and advanced modeling, SKIM's new mobile-only implicit application opens the door to a new generation of research solutions.
“Swipe left, swipe right” – Breakthrough implicit mobile research techniquesSKIM
Find out more at http://skimgroup.com/unspoken-implicit-research
Key learnings:
- Using “natural” mobile techniques such as tapping and swiping as basis for your survey design
- Capturing non-rational drivers through a mobile friendly research design based on implicit research techniques
- Swiping, Trade-offs and Heatmaps: introducing three examples of intuitive mobile techniques
- How do the results compare to a) traditional survey design b) amongst the new methods
Unspoken™: Swipe left, swipe right - The only way is mobileSKIM
Everyone agrees that market research nowadays must be mobile-friendly due to the new reality of how mobile devices have become the center of our daily routines. Yet, how this goes beyond a mobile view only is not always clear. This is why we developed Unspoken™, our new mobile research method with a purpose to accurately predict how your consumers behave and decide.
We presented this fresh approach to engaging mobile surveys at the biggest Netherlands' Marketing & Insights Events (MIE)' 17, which was held on February 1-2, 2017.
Webinar "Understanding millennials requires adapting the research approach"SKIM
In this 30-minute SKIM webinar on February 2, 2017 we shared with you what we learned about millennials from a mobile research-based study we conducted in the telecom industry.
Click here for more info https://goo.gl/j3zXf8
Insights:
• New research technologies designed for the smartphone, e.g. “swiping” MaxDiff
• Rational vs emotional: which statements drive decisions amongst millennials
• How different styles of visualization influence millennials’ decision making
IIeX EU 2017 - How new mobile research techniques can create better insightsSKIM
The world around us is changing rapidly, and the market research industry must adjust accordingly. Key industry trends are the need for speed, the growing proliferation of mobile, and bridging rational and emotional drivers.
To fit with these requirements, we are introducing Unspoken™. By combining intuitive mobile techniques with psychological theory and advanced modeling, this mobile-only implicit application opens the door to a new generation of research solutions.
Find out more https://goo.gl/H6IbzD
Launching a breakthrough innovation: Unspoken™ SKIM
Presented by Paul Janssen, VP North America
Find out more at http://skimgroup.com/webinar-implicit-research-technique.
Have you been wondering what the new generation of mobile research will look like? Or how we can better capture both the conscious and subconscious processes of the brain by leveraging big implicit research techniques in an efficient and actionable way?
In this webinar Paul Janssen, VP North America at SKIM and one of the people behind our latest innovation, will introduce Unspoken ™, a new technology that combines a breakthrough implicit research technique with an engaging mobile interface.
By leveraging native mobile swiping and tapping techniques consumers are given an intuitive user experience that helps connect with their natural behavior. Advanced algorithms rooted in SKIM's choice modeling expertise, then use the recorded choices and reaction times to model outcomes that are more reflective of the instinctual behavior consumers display in market.
Unspoken ™ can be used for a variety of applications like screening variants, packs and promotions. However, the main focus of the webinar will be on brand communications. More specifically, we will explore how we can use Unspoken ™ to identify which ads or messages break through the clutter and convert shoppers into buyers once they have arrived at the moment of truth like a shelf or website.
Webinar "Insight Acceleration: From 6 weeks to 22 hours of research" SKIM
On March 2, 2017 we shared with you the 3-year lessons that we and AT&T have learned so far: the steps, challenges, processes, and changes we both needed in order to deliver insights faster. We also showed example templates and processes we are using with AT&T to achieve fast turnaround.
Check out the recording https://goo.gl/08KCMY
Redefining the role of patient support programs: Shifting the focus towards p...SKIM
Presented by:
Alex Zhu, Manager
Ariel Herrlich, Analyst
The recent shift toward consumerism and patient empowerment is driving companies to reevaluate the role and design of patient support programs. Historically, pharmaceutical manufacturers implemented support programs largely as a way to address patient non-adherence.
These programs were often single-based solutions designed to meet mass market needs. Next generation patient support programs will go beyond simple adherence to address holistic disease management through individualized, patient-centric service offerings.
Using a case study, we illustrated:
- How to evaluate your current patient support program offerings, using a combination of standard and non-standard metrics and exercises
- Re-define what “value” means in a world of patient-centricity and personalized care
- Assess the impact/ROI of potential new service offerings and enhancements
Webinar "Brand driver analysis - extract more juice from your brand tracking ...SKIM
Watch the on-demand webinar here https://hubs.ly/H08X02l0
In this month’s 30-minute SKIM webinar, Juan Tello, our Senior VP Americas and Advanced Modeling expert, shared how we helped several brands understand what factors drive success in their category, which brands own these drivers and what are white space market opportunities – by analyzing their existing brand tracking data.
A view of the customer experience through the consumer journeySKIM
Customer satisfaction can be measured across the consumer journey, each point being evaluated and rated by customers on how satisfied they are at that specific point in time. However, with the consumer journey becoming so intricate and interconnected through numerous channels, looking at these individual points in isolation is no longer accurate and can be deceiving.
Hence, marketers should go beyond traditional metrics to determine and understand customer experience within the context of consumer journey.
We shared insights from our journey mapping studies as we see tremendous value when understanding customer experience from this perspective.
SDTM Training for personnel with Junior and Intermediate level Clinical Trial Experience. Covers summary of most domains. Salient features include order of domain creation, importance of making programming Data/Metadata Driven, Nature of Clinical Raw Data, Summary of the Clinical Trial process with regards to the data flow to arrive at the Study data to be submitted to regulatory authorities like FDA, Importance of deriving ADAM from SDTM and not directly from raw data, Information has been put together from variety of sources including my own programming work.
Working the Science and Regulations Harder to Win Your Drug and Device CasesSara Dunlap
This webinar will teach critical scientific principles related to the regulatory framework as they pertain to drug and medical device litigation for seasoned in house and outside counsel alike. Examples of topics that will be covered include safety signaling and pharmacovigilance, epidemiological and randomized controlled trial study design, risk management principles, causality assessment, and the strategic role of regulatory guidelines and compliance.
Insights into patient preferences on telemedicine, wearables
and post-discharge care - We asked more than 2,000 Americans how they currently connect with healthcare providers. Their answers may surprise you - This survey was conducted online within the United States by Harris Poll on behalf of Salesforce from June 8-10, 2016, among 2,025 U.S. adults ages 18 and older, among whom 1,736 have health insurance and a primary care doctor. This online survey is not based on a probability sample, and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables, please contact Joel Steinfeld at jsteinfeld@salesforce.com.
With @Atreja at the NODE Health Conference - Digital Medicine http://digitalmedicineconference.com/ on the events and studies which moved the field forward
The Randomized Controlled Trial: The Gold Standard of Clinical Science and a ...marcus evans Network
Tim Fayram, St. Jude Medical Inc. - Speaker at the marcus evans Medical Device R&D Summit Fall 2013, held in Palm Beach, FL delivered his presentation entitled The Randomized Controlled Trial: The Gold Standard of Clinical Science and a Barrier to Innovation?
Turning tactical discounts into an effective price promotion strategy - EPP P...SKIM
Download this deck https://hubs.ly/H09r22T0
In the EPP Global Pricing Forum, we held a boot camp on turning tactical discounts into an effective price promotion strategy.
Mobile Ready Hero Images: Optimizing eContent for faster, easier online shoppingSKIM
Download the deck https://hubs.ly/H09fGHX0
Presented at the OmniShopper International, we shared how how Hero Images were optimized with actionable research and are now becoming a GS1 industry standard for retailers and CPG manufacturers.
Turning a corner on negative perceptions of refugees in europeSKIM
Download the presentation here https://hubs.ly/H08VB_40
Our study reveals there is opportunity to turn a corner on negative perceptions. After isolating the most important barriers to address, targeted communication increases attitudinal and behavioral support for refugees.
However, we find some barriers are easier to overcome than others, the most effective form of communication depends on the barrier being tackled and outcomes differ in terms of the type of support triggered.
How new mobile research can help you uncover true consumer preferences in eme...SKIM
Watch the on-demand webinar here https://hubs.ly/H08Stw_0
In this free 30-minute webinar, we shared with you how our newest research method leverages mobile technology to create intuitive exercises and reduce natural urges to comply with social norms.
Co-presenting a webinar on “Long term impact of promotions” with PepsiCo SKIM
Download this presentation on our website https://goo.gl/NW6biM
Together with PepsiCo, we have run a pilot study where we modeled the market from two perspectives: past sales data as well as an ad hoc conjoint study in order to find a way to identify the best (new) promotions, and assess both their short term and their long term impact.
Iterative Multilevel Empirical Bayes (IMEB): An efficient flexible and robust...SKIM
Download this presentation on our website https://goo.gl/EVrXiy
We described an approach that fixes the upper level prior based on the data (hence Empirical Bayes) and cross-validation of a scale parameter. This fixed prior eliminates MCMC iterations, making it much faster than standard HB. The Empirical Bayes approach also avoids issues of inadequate convergence and improper scaling that may occur with MCMC.
"Big simulators with dozens of products: Which conjoint method is most suitab...SKIM
Download this presentation https://goo.gl/c77VU7
The key question in this presentation was to check what extent the discrepancy between the number of concepts in a task (3, or 4) versus the number of products in the conjoint simulation model (20, or 50) may influence the results of the study, by comparing CBC, ACBC and PBC (preference based conjoint).
Co-presented with Mars Petcare on "Disrupting the habitual consumer decision ...SKIM
Download this presentation on our website https://goo.gl/bNrPri
In the new omnichannel reality of consumer behaviors, we and Mars Petcare talked about a new framework of uncovering consumer decision journey insights centered around disruption and cross-category learnings when applying this framework. By adopting a designer mentality, we also shared tips and best practices on activating journey insights to create best-in-class consumer experiences.
We shared with you our pilot study on "The Patient Journey Evolution" at the 3-day PMRG CONNECT 2017 event.
Traditional patient journey research often falls short on actions and serves primarily as a descriptive framework used to generally understand how patients progress from symptoms to treatment. But what if we want to get more from the research?
Can patient journey research answer key business questions and ultimately, what do we hope to get out of patient journey research? Can we borrow from work we’re doing in consumer research to inform us?
Find out more https://goo.gl/JZpCUH
ESOMAR LATAM 2017 - Swipe right, swipe left: Implicit research metric via eng...SKIM
We presented this fresh approach to engaging mobile surveys at Latin America’s largest regional event, ESOMAR LATAM, which was held on April 5-7, 2017 in Mexico City.
Find out more https://goo.gl/8QwgxN
Webinar "How to screen 100+ concepts with MaxDiff"SKIM
In this 30-minute webinar on April 6th, 2017 we shared with you various advanced approaches. E.g. what if you want to screen 20, 50, or even 100+ concepts? In addition, we explained how to define a cut-off point that distinguishes the good from the bad.
The following points were discussed:
- Why limit the number of concepts per screen
- Sparse versus Express MaxDiff
- Thompson Sampling MaxDiff
- Purchase Intent: Anchor versus Dual Response None
Find out more https://goo.gl/KUj5zZ
How new mobile research techniques create better insightsSKIM
We were thrilled to share with you a good news: Our Unspoken™ story was nominated for the Paper of the Year Award at the Insight Show 2017 and that we presented it at the main stage with 200+ audience.
During our Unspoken™ presentation, we shared with you about how the “natural” mobile research techniques we developed can capture both rational – emotional drivers in decision-making and increase participants’ engagement.
Find out more https://goo.gl/5t4z7Q
Knowing that shoppers are increasingly engaging with more than one channel in their decision journey, it’s thus important to understand each step and activity along the way.
During the Quirk's Event in Brooklyn on March 22, we and Mars Petcare explained how to map customer journeys to optimize touch points and influence the interaction of channel behavior.
Find out more https://goo.gl/6EvRTg
Recruiting in the Digital Age: A Social Media MasterclassLuanWise
In this masterclass, presented at the Global HR Summit on 5th June 2024, Luan Wise explored the essential features of social media platforms that support talent acquisition, including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok.
Business Valuation Principles for EntrepreneursBen Wann
This insightful presentation is designed to equip entrepreneurs with the essential knowledge and tools needed to accurately value their businesses. Understanding business valuation is crucial for making informed decisions, whether you're seeking investment, planning to sell, or simply want to gauge your company's worth.
Discover the innovative and creative projects that highlight my journey throu...dylandmeas
Discover the innovative and creative projects that highlight my journey through Full Sail University. Below, you’ll find a collection of my work showcasing my skills and expertise in digital marketing, event planning, and media production.
An introduction to the cryptocurrency investment platform Binance Savings.Any kyc Account
Learn how to use Binance Savings to expand your bitcoin holdings. Discover how to maximize your earnings on one of the most reliable cryptocurrency exchange platforms, as well as how to earn interest on your cryptocurrency holdings and the various savings choices available.
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Sustainability has become an increasingly critical topic as the world recognizes the need to protect our planet and its resources for future generations. Sustainability means meeting our current needs without compromising the ability of future generations to meet theirs. It involves long-term planning and consideration of the consequences of our actions. The goal is to create strategies that ensure the long-term viability of People, Planet, and Profit.
Leading companies such as Nike, Toyota, and Siemens are prioritizing sustainable innovation in their business models, setting an example for others to follow. In this Sustainability training presentation, you will learn key concepts, principles, and practices of sustainability applicable across industries. This training aims to create awareness and educate employees, senior executives, consultants, and other key stakeholders, including investors, policymakers, and supply chain partners, on the importance and implementation of sustainability.
LEARNING OBJECTIVES
1. Develop a comprehensive understanding of the fundamental principles and concepts that form the foundation of sustainability within corporate environments.
2. Explore the sustainability implementation model, focusing on effective measures and reporting strategies to track and communicate sustainability efforts.
3. Identify and define best practices and critical success factors essential for achieving sustainability goals within organizations.
CONTENTS
1. Introduction and Key Concepts of Sustainability
2. Principles and Practices of Sustainability
3. Measures and Reporting in Sustainability
4. Sustainability Implementation & Best Practices
To download the complete presentation, visit: https://www.oeconsulting.com.sg/training-presentations
Enterprise Excellence is Inclusive Excellence.pdfKaiNexus
Enterprise excellence and inclusive excellence are closely linked, and real-world challenges have shown that both are essential to the success of any organization. To achieve enterprise excellence, organizations must focus on improving their operations and processes while creating an inclusive environment that engages everyone. In this interactive session, the facilitator will highlight commonly established business practices and how they limit our ability to engage everyone every day. More importantly, though, participants will likely gain increased awareness of what we can do differently to maximize enterprise excellence through deliberate inclusion.
What is Enterprise Excellence?
Enterprise Excellence is a holistic approach that's aimed at achieving world-class performance across all aspects of the organization.
What might I learn?
A way to engage all in creating Inclusive Excellence. Lessons from the US military and their parallels to the story of Harry Potter. How belt systems and CI teams can destroy inclusive practices. How leadership language invites people to the party. There are three things leaders can do to engage everyone every day: maximizing psychological safety to create environments where folks learn, contribute, and challenge the status quo.
Who might benefit? Anyone and everyone leading folks from the shop floor to top floor.
Dr. William Harvey is a seasoned Operations Leader with extensive experience in chemical processing, manufacturing, and operations management. At Michelman, he currently oversees multiple sites, leading teams in strategic planning and coaching/practicing continuous improvement. William is set to start his eighth year of teaching at the University of Cincinnati where he teaches marketing, finance, and management. William holds various certifications in change management, quality, leadership, operational excellence, team building, and DiSC, among others.
Affordable Stationery Printing Services in Jaipur | Navpack n PrintNavpack & Print
Looking for professional printing services in Jaipur? Navpack n Print offers high-quality and affordable stationery printing for all your business needs. Stand out with custom stationery designs and fast turnaround times. Contact us today for a quote!
"𝑩𝑬𝑮𝑼𝑵 𝑾𝑰𝑻𝑯 𝑻𝑱 𝑰𝑺 𝑯𝑨𝑳𝑭 𝑫𝑶𝑵𝑬"
𝐓𝐉 𝐂𝐨𝐦𝐬 (𝐓𝐉 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬) is a professional event agency that includes experts in the event-organizing market in Vietnam, Korea, and ASEAN countries. We provide unlimited types of events from Music concerts, Fan meetings, and Culture festivals to Corporate events, Internal company events, Golf tournaments, MICE events, and Exhibitions.
𝐓𝐉 𝐂𝐨𝐦𝐬 provides unlimited package services including such as Event organizing, Event planning, Event production, Manpower, PR marketing, Design 2D/3D, VIP protocols, Interpreter agency, etc.
Sports events - Golf competitions/billiards competitions/company sports events: dynamic and challenging
⭐ 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐬:
➢ 2024 BAEKHYUN [Lonsdaleite] IN HO CHI MINH
➢ SUPER JUNIOR-L.S.S. THE SHOW : Th3ee Guys in HO CHI MINH
➢FreenBecky 1st Fan Meeting in Vietnam
➢CHILDREN ART EXHIBITION 2024: BEYOND BARRIERS
➢ WOW K-Music Festival 2023
➢ Winner [CROSS] Tour in HCM
➢ Super Show 9 in HCM with Super Junior
➢ HCMC - Gyeongsangbuk-do Culture and Tourism Festival
➢ Korean Vietnam Partnership - Fair with LG
➢ Korean President visits Samsung Electronics R&D Center
➢ Vietnam Food Expo with Lotte Wellfood
"𝐄𝐯𝐞𝐫𝐲 𝐞𝐯𝐞𝐧𝐭 𝐢𝐬 𝐚 𝐬𝐭𝐨𝐫𝐲, 𝐚 𝐬𝐩𝐞𝐜𝐢𝐚𝐥 𝐣𝐨𝐮𝐫𝐧𝐞𝐲. 𝐖𝐞 𝐚𝐥𝐰𝐚𝐲𝐬 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐭𝐡𝐚𝐭 𝐬𝐡𝐨𝐫𝐭𝐥𝐲 𝐲𝐨𝐮 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐚 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐨𝐮𝐫 𝐬𝐭𝐨𝐫𝐢𝐞𝐬."
Building Your Employer Brand with Social MediaLuanWise
Presented at The Global HR Summit, 6th June 2024
In this keynote, Luan Wise will provide invaluable insights to elevate your employer brand on social media platforms including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok. You'll learn how compelling content can authentically showcase your company culture, values, and employee experiences to support your talent acquisition and retention objectives. Additionally, you'll understand the power of employee advocacy to amplify reach and engagement – helping to position your organization as an employer of choice in today's competitive talent landscape.
Personal Brand Statement:
As an Army veteran dedicated to lifelong learning, I bring a disciplined, strategic mindset to my pursuits. I am constantly expanding my knowledge to innovate and lead effectively. My journey is driven by a commitment to excellence, and to make a meaningful impact in the world.
Implicitly or explicitly all competing businesses employ a strategy to select a mix
of marketing resources. Formulating such competitive strategies fundamentally
involves recognizing relationships between elements of the marketing mix (e.g.,
price and product quality), as well as assessing competitive and market conditions
(i.e., industry structure in the language of economics).
11. Account for complexity simply
Simplify data collection, but account for market complexity
1 2 3 4
15 minute
online survey
Forms via
Direct mail
Use mobile app
in the moment
Audio recording
16. Qualitative data provides depth
Collection of focused, relevant information
(Very) Good OS/PFS
Good safety profile
Good experience in
Melanoma
No Docetaxel: wide
applicability
It is a single agent
Oral formulation
advantageous
3%60% 17% 33% 3
40% 7% 17% 20%
0% 0% 0%
23%
0% 0% 0% 10%
0% 0% 0% 13%
13% 0% 0% 0%
Product E ProductA Product B Product D
17. Benefits…
Robust data – patient records
without associated problems
Applications in market potential,
segmentation, Tx pathway
Less post-rationalisation,
responses close to point of prescription
Accounts for indications with wide variety of patient types,
or highly individualised treatment (e.g. biomarker-based treatment)
20. Robert Dossin
Client Solutions Director Europe
Based in Rotterdam
r.dossin@skimgroup.com
Contact me
skimgroup.com
@SKIMgroup
SKIMgroup
SKIMgroup
20
Mike Mabey
VP Client Solutions Americas
Based in Atlanta
m.mabey@skimgroup.com